|
Report No. : |
321095 |
|
Report Date : |
06.05.2015 |
IDENTIFICATION DETAILS
|
Name : |
ELEKTA LIMITED |
|
|
|
|
Formerly Known As : |
ELEKTA ONCOLOGY SYSTEMS LTD REFAL 496 LIMITED |
|
|
|
|
Registered Office : |
Linac House Fleming Way Crawley RH10 9RR |
|
|
|
|
Country : |
United Kingdom |
|
|
|
|
Financials (as on) : |
30.04.2014 |
|
|
|
|
Date of Incorporation : |
02.09.1996 |
|
|
|
|
Com. Reg. No.: |
03244454 |
|
|
|
|
Legal Form : |
Private limited with Share Capital |
|
|
|
|
Line of Business : |
Manufacture and sale of medical capital equipment and associated software specifically for the treatment of cancer. |
|
|
|
|
No. of Employees : |
595 (2013) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2014
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
United Kingdom |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
UNITED KINGDOM - ECONOMIC OVERVIEW
The UK, a leading trading power and financial center, is the third largest economy in Europe after Germany and France. Agriculture is intensive, highly mechanized, and efficient by European standards, producing about 60% of food needs with less than 2% of the labor force. The UK has large coal, natural gas, and oil resources, but its oil and natural gas reserves are declining and the UK became a net importer of energy in 2005. Services, particularly banking, insurance, and business services, are key drivers of British GDP growth. Manufacturing, meanwhile, has declined in importance but still accounts for about 10% of economic output. In 2008, the global financial crisis hit the economy particularly hard, due to the importance of its financial sector. Falling home prices, high consumer debt, and the global economic slowdown compounded Britain's economic problems, pushing the economy into recession in the latter half of 2008 and prompting the then BROWN (Labour) government to implement a number of measures to stimulate the economy and stabilize the financial markets. Facing burgeoning public deficits and debt levels, in 2010 the CAMERON-led coalition government (between Conservatives and Liberal Democrats) initiated an austerity program, which aimed to lower London's budget deficit from about 11% of GDP in 2010 to nearly 1% by 2015. The CAMERON government raised the value added tax from 17.5% to 20% in 2011. It has pledged to reduce the corporation tax rate to 20% by 2015. However, the deficit still remains one of the highest in the G7, standing at 5.8% in 2013. The Bank of England (BoE) implemented an asset purchase program of �375 billion (approximately $586 billion) as of December 2014. During times of economic crisis, the BoE coordinates interest rate moves with the European Central Bank, but Britain remains outside the European Economic and Monetary Union (EMU). In 2012, weak consumer spending and subdued business investment weighed on the economy, however, in 2013 GDP grew 1.8%, accelerating unexpectedly because of greater consumer spending and a recovering housing market.
|
Source
: CIA |
ELEKTA LIMITED
03244454
Active - Accounts Filed
LINAC HOUSE
FLEMING WAY
CRAWLEY
RH10 9RR
Registered Address LINAC HOUSE Trading
Address Linac House
FLEMING WAY Fleming
Way
CRAWLEY Crawley
West
Sussex
RH10 9RR RH10
9RR
Website Address http://www.elekta.com
Telephone Number 01293544422 Fax
Number
TPS No FPS
No
Incorporation Date 02/09/1996
Previous Name ELEKTA ONCOLOGY
SYSTEMS LTD
Type Private limited
with Share Capital
FTSE Index - Date
of Change 22/07/2003
Filing Date of Accounts 19/12/2014 Currency
GBP
Share Capital £22,201,001 SIC07
32500
Charity Number -
SIC07 Description Manufacture Of
Medical And Dental Instruments And Supplies
Principal Activity
Manufacture and
sale of medical capital equipment and associated software specifically for the
treatment
|
Year to Date |
Turnover |
Pre Tax Profit |
Shareholder |
Funds Employees |
|
30/04/2014 |
£490,679,000 |
£56,591,000 |
£166,411,000 |
- |
|
30/04/2013 |
£442,470,000 |
£62,825,000 |
£144,945,000 |
595 |
|
30/04/2012 |
£352,547,000 |
£50,595,000 |
£105,761,000 |
537 |
Total Mortgage 1
Outstanding 0
Satisfied 1
Total Number
of Documented Trade 0
Total Value of
Documented Trade £0
This company has been treated as a Large company in respect of the rating/limit generated.
This company's return on total assets employed ratio indicates a highly efficient use of assets.
This company has only made late payments on a low percentage of invoices.
This company's ratio of total liabilities to total assets indicates the presence of moderate equity funding.
The company has more cash than short term bank borrowings.
This company trades in an industry with a moderate level of corporate failures.
Total Number of Exact
CCJs - 0 Total Value of Exact CCJs –
Total Number
of Possible CCJs - 0 Total Value of Possible
CCJs -
Total Number
of Satisfied CCJs - 0 Total Value of Satisfied
CCJs -
Total Number
of Writs - -
Total Current Directors 7
Total Current Secretaries 1
Total Previous Directors / Company
Secretaries 24
|
Name |
Per Hakan Bergstrom |
Date of Birth |
17/01/1956 |
|
Officers Title |
Mr |
Nationality |
Swedish |
|
Present Appointments |
2 |
Function |
Director |
|
Appointment Date |
01/10/2001 |
|
|
|
Address |
Tryffelstigen 2, Nykoping, S-611 63 |
|
|
|
Name |
Johan Axel Edvin Alfred Sedihn |
Date of Birth |
14/05/1965 |
|
Officers Title |
Mr |
Nationality |
Swedish |
|
Present Appointments |
2 |
Function |
Director |
|
Appointment Date |
01/11/2005 |
|
|
|
Address |
Wimlands Wimlands Lane, Faygate, Horsham, West Sussex, RH12 4SP |
|
|
|
Name |
Lutz Hagen Schaefer |
Date of Birth |
10/03/1967 |
|
Officers Title |
Mr |
Nationality |
German |
|
Present Appointments |
1 |
Function |
Director |
|
Appointment Date |
05/10/2011 |
|
|
|
Address |
Linac House, Fleming Way, Crawley, West
Sussex, RH10 9RR |
|
|
|
Name |
William Dean Yaeger |
Date of Birth |
22/10/1961 |
|
Officers Title |
Mr |
Nationality |
American |
|
Present Appointments |
3 |
Function |
Director |
|
Appointment Date |
27/04/2012 |
|
|
|
Address |
Linac House Fleming Way, Crawley, West
Sussex, RH10 9RR |
|
|
|
Name |
Steven Mark Wort |
Date of Birth |
04/04/1963 |
|
Officers Title |
Mr |
Nationality |
British |
|
Present Appointments |
1 |
Function |
Director |
|
Appointment Date |
08/03/2013 |
|
|
|
Address |
Linac House, Fleming Way, Crawley, West
Sussex, RH10 9RR |
|
|
|
Name |
Thomas Tetley Beazley |
Date of Birth |
26/03/1961 |
|
Officers Title |
Mr |
Nationality |
British |
|
Present Appointments |
1 |
Function |
Director |
|
Appointment Date |
08/03/2013 |
|
|
|
Address |
Linac House, Fleming Way, Crawley, West
Sussex, RH10 9RR |
|
|
|
Name |
David Ian Alexander |
Date of Birth |
10/03/1958 |
|
Officers Title |
Mr |
Nationality |
British |
|
Present Appointments |
1 |
Function |
Director |
|
Appointment Date |
08/03/2013 |
|
|
|
Address |
Linac House, Fleming Way, Crawley, West
Sussex, RH10 9RR |
|
|
|
Name |
Samantha Cookman |
Date of Birth |
- |
|
Officers Title |
Mrs |
Nationality |
|
|
Present Appointments |
1 |
Function |
Company Secretary |
|
Appointment Date |
08/03/2013 |
|
|
|
Address |
Linac House, Fleming Way, Crawley, West Sussex, RH10 9RR |
|
|
|
Name |
Currency |
Share Count |
Share Type |
Nominal |
% of Total Share Count |
|
ELEKTA HOLDINGS LTD |
GBP |
22,201,001 |
ORDINARY |
1 |
100 |
|
Date Of Accounts |
30/04/14 |
(%) |
30/04/13 |
(%) |
30/04/12 |
(%) |
30/04/11 |
(%) |
30/04/10 |
|
Weeks |
52 |
(%) |
52 |
(%) |
52 |
(%) |
52 |
(%) |
52 |
|
Currency |
GBP |
(%) |
GBP |
(%) |
GBP |
(%) |
GBP |
(%) |
GBP |
|
Consolidated A/cs |
N |
(%) |
N |
(%) |
N |
(%) |
N |
(%) |
N |
|
Turnover |
£490,679,000 |
10.9% |
£442,470,000 |
25.5% |
£352,547,000 |
15.5% |
£305,198,000 |
14.4% |
£266,820,000 |
|
Export |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
Cost of Sales |
£331,987,000 |
16.4% |
£285,318,000 |
29.2% |
£220,892,000 |
11.7% |
£197,716,000 |
18.2% |
£167,295,000 |
|
Gross Profit |
£158,692,000 |
1% |
£157,152,000 |
19.4% |
£131,655,000 |
22.5% |
£107,482,000 |
8% |
£99,525,000 |
|
Wages & Salaries |
- |
- |
£34,474,000 |
12.4% |
£30,663,000 |
5.2% |
£29,151,000 |
14% |
£25,578,000 |
|
Directors Emoluments |
£1,776,000 |
59.6% |
£1,113,000 |
94.2% |
£573,000 |
4.4% |
£549,000 |
24.5% |
£441,000 |
|
Operating Profit |
£58,773,000 |
-8.8% |
£64,470,000 |
23.7% |
£52,130,000 |
72.9% |
£30,158,000 |
-10.8% |
£33,805,000 |
|
Depreciation |
£3,119,000 |
12.5% |
£2,773,000 |
28.6% |
£2,157,000 |
24.8% |
£1,728,000 |
1.2% |
£1,708,000 |
|
Audit Fees |
£76,000 |
- |
£76,000 |
-27.6% |
£105,000 |
12.9% |
£93,000 |
3.3% |
£90,000 |
|
Interest Payments |
£2,223,000 |
25.8% |
£1,767,000 |
9.3% |
£1,617,000 |
46.3% |
£1,105,000 |
48.1% |
£746,000 |
|
Pre Tax Profit |
£56,591,000 |
-9.9% |
£62,825,000 |
24.2% |
£50,595,000 |
73.9% |
£29,093,000 |
-12.1% |
£33,083,000 |
|
Taxation |
-£7,521,000 |
43.1% |
-£13,209,000 |
-23.2% |
-£10,721,000 |
-51.3% |
-£7,087,000 |
22% |
-£9,085,000 |
|
Profit After Tax |
£49,070,000 |
-1.1% |
£49,616,000 |
24.4% |
£39,874,000 |
81.2% |
£22,006,000 |
-8.3% |
£23,998,000 |
|
Dividends Payable |
£33,000,000 |
32% |
£25,000,000 |
- |
- |
- |
- |
-100% |
£25,000,000 |
|
Retained Profit |
£16,070,000 |
-34.7% |
£24,616,000 |
-38.3% |
£39,874,000 |
81.2% |
£22,006,000 |
999.9% |
-£1,002,000 |
|
Date Of Accounts |
30/04/14 |
(%) |
30/04/13 |
(%) |
30/04/12 |
(%) |
30/04/11 |
(%) |
30/04/10 |
|
Tangible Assets |
£20,634,000 |
72.3% |
£11,975,000 |
-11.1% |
£13,466,000 |
29.7% |
£10,381,000 |
24.3% |
£8,349,000 |
|
Intangible Assets |
£42,354,000 |
42.2% |
£29,779,000 |
178.6% |
£10,687,000 |
164% |
£4,048,000 |
-15% |
£4,763,000 |
|
Total Fixed Assets |
£62,988,000 |
50.9% |
£41,754,000 |
72.9% |
£24,153,000 |
67.4% |
£14,429,000 |
10% |
£13,112,000 |
|
Stock |
£44,627,000 |
15.7% |
£38,561,000 |
52.6% |
£25,270,000 |
24.2% |
£20,347,000 |
-13.2% |
£23,447,000 |
|
Trade Debtors |
£134,769,000 |
60.6% |
£83,898,000 |
85% |
£45,346,000 |
-23.7% |
£59,452,000 |
40.3% |
£42,373,000 |
|
Cash |
£28,937,000 |
-35.7% |
£44,998,000 |
- |
0 |
- |
0 |
- |
0 |
|
Other Debtors |
£139,471,000 |
-15.9% |
£165,832,000 |
21% |
£137,031,000 |
35.9% |
£100,835,000 |
10.8% |
£90,970,000 |
|
Miscellaneous Current Assets |
0 |
- |
0 |
- |
0 |
- |
0 |
- |
0 |
|
Total Current Assets |
£347,804,000 |
4.4% |
£333,289,000 |
60.5% |
£207,647,000 |
15% |
£180,634,000 |
15.2% |
£156,790,000 |
|
Trade Creditors |
£64,869,000 |
3% |
£62,982,000 |
65.3% |
£38,094,000 |
48.5% |
£25,654,000 |
18.6% |
£21,633,000 |
|
Bank Loans & Overdrafts |
0 |
- |
0 |
-100% |
£2,216,000 |
-63.3% |
£6,046,000 |
4% |
£5,811,000 |
|
Other Short Term Finance |
£51,100,000 |
-0.9% |
£51,578,000 |
58.7% |
£32,506,000 |
13.9% |
£28,544,000 |
-19.3% |
£35,386,000 |
|
Miscellaneous Current Liabilities |
£107,893,000 |
12.7% |
£95,754,000 |
152.7% |
£37,886,000 |
-28.9% |
£53,298,000 |
13.1% |
£47,132,000 |
|
Total Current Liabilities |
£223,862,000 |
6.4% |
£210,314,000 |
90% |
£110,702,000 |
-2.5% |
£113,542,000 |
3.3% |
£109,962,000 |
|
Bank Loans & Overdrafts and LTL |
£20,519,000 |
3.7% |
£19,784,000 |
12.7% |
£17,553,000 |
-19% |
£21,680,000 |
-0.9% |
£21,870,000 |
|
Other Long Term Finance |
£13,500,000 |
- |
£13,500,000 |
- |
£13,500,000 |
- |
£13,500,000 |
- |
£13,500,000 |
|
Total Long Term Liabilities |
£20,519,000 |
3.7% |
£19,784,000 |
29% |
£15,337,000 |
-1.9% |
£15,634,000 |
-2.6% |
£16,059,000 |
.
|
Date Of Accounts |
30/04/14 |
(%) |
30/04/13 |
(%) |
30/04/12 |
(%) |
30/04/11 |
(%) |
30/04/10 |
|
Called Up Share Capital |
£22,201,000 |
- |
£22,201,000 |
- |
£22,201,000 |
- |
£22,201,000 |
- |
£22,201,000 |
|
P & L Account Reserve |
£142,208,000 |
15.9% |
£122,744,000 |
46.9% |
£83,560,000 |
91.3% |
£43,686,000 |
101.5% |
£21,680,000 |
|
Revaluation Reserve |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
Sundry Reserves |
£2,002,000 |
- |
- |
- |
- |
- |
- |
- |
- |
|
Shareholder Funds |
£166,411,000 |
14.8% |
£144,945,000 |
37% |
£105,761,000 |
60.5% |
£65,887,000 |
50.1% |
£43,881,000 |
|
Date Of Accounts |
30/04/14 |
(%) |
30/04/13 |
(%) |
30/04/12 |
(%) |
30/04/11 |
(%) |
30/04/10 |
|
Net Worth |
£124,057,000 |
7.7% |
£115,166,000 |
21.1% |
£95,074,000 |
53.7% |
£61,839,000 |
58.1% |
£39,118,000 |
|
Working Capital |
£123,942,000 |
0.8% |
£122,975,000 |
26.9% |
£96,945,000 |
44.5% |
£67,092,000 |
43.3% |
£46,828,000 |
|
Total Assets |
£410,792,000 |
9.5% |
£375,043,000 |
61.8% |
£231,800,000 |
18.8% |
£195,063,000 |
14.8% |
£169,902,000 |
|
Total Liabilities |
£244,381,000 |
6.2% |
£230,098,000 |
82.6% |
£126,039,000 |
-2.4% |
£129,176,000 |
2.5% |
£126,021,000 |
|
Net Assets |
£166,411,000 |
14.8% |
£144,945,000 |
37% |
£105,761,000 |
60.5% |
£65,887,000 |
50.1% |
£43,881,000 |
|
Date Of Accounts |
30/04/14 |
(%) |
30/04/13 |
(%) |
30/04/12 |
(%) |
30/04/11 |
(%) |
30/04/10 |
|
Net Cashflow from Operations |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
Net Cashflow before Financing |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
Net Cashflow from Financing |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
Increase in Cash |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
Date Of Accounts |
30/04/14 |
(%) |
30/04/13 |
(%) |
30/04/12 |
(%) |
30/04/11 |
(%) |
30/04/10 |
|
Contingent Liability |
YES |
- |
YES |
- |
YES |
- |
YES |
- |
YES |
|
Capital Employed |
£186,930,000 |
13.5% |
£164,729,000 |
36% |
£121,098,000 |
48.5% |
£81,521,000 |
36% |
£59,940,000 |
|
Number of Employees |
- |
- |
595 |
10.8% |
537 |
4.9% |
512 |
4.9% |
488 |
|
Auditors |
PRICEWATERHOUSECOOPERS LLP |
||||||||
|
Auditor Comments |
The audit report contains no adverse comments |
||||||||
|
Bankers |
HSBC BANK PLC |
||||||||
|
Bank Branch Code |
|||||||||
|
Date Of Accounts |
30/04/14 |
30/04/13 |
30/04/12 |
30/04/11 |
30/04/10 |
|
Pre-tax profit margin % |
11.53 |
14.20 |
14.35 |
9.53 |
12.40 |
|
Current ratio |
1.55 |
1.58 |
1.88 |
1.59 |
1.43 |
|
Sales/Net Working Capital |
3.96 |
3.60 |
3.64 |
4.55 |
5.70 |
|
Gearing % |
12.30 |
13.60 |
16.60 |
32.90 |
49.80 |
|
Equity in % |
45.20 |
42 |
47.80 |
34.50 |
26.60 |
|
Creditor Days |
48.12 |
51.81 |
39.33 |
30.59 |
29.51 |
|
Debtor Days |
99.97 |
69.01 |
46.81 |
70.90 |
57.80 |
|
Liquidity/Acid Test |
1.35 |
1.40 |
1.64 |
1.41 |
1.21 |
|
Return On Capital Employed % |
30.27 |
38.13 |
41.78 |
35.68 |
55.19 |
|
Return On Total Assets Employed % |
13.77 |
16.75 |
21.82 |
14.91 |
19.47 |
|
Current Debt Ratio |
1.34 |
1.45 |
1.04 |
1.72 |
2.50 |
|
Total Debt Ratio |
1.46 |
1.58 |
1.19 |
1.96 |
2.87 |
|
Stock Turnover Ratio % |
9.09 |
8.71 |
7.16 |
6.66 |
8.78 |
|
Return on Net Assets Employed % |
34 |
43.34 |
47.83 |
44.15 |
75.39 |
There are no notes to display.
No Status History found
|
Date |
Description |
|
12/01/2015 |
New Accounts Filed |
|
12/01/2015 |
New Accounts Filed |
|
03/10/2014 |
Annual Returns |
|
16/10/2013 |
New Accounts Filed |
|
16/10/2013 |
New Accounts Filed |
|
13/09/2013 |
Annual Returns |
|
15/03/2013 |
New Board Member Mr D.I. Alexander appointed |
|
15/03/2013 |
New Board Member Mr T.T. Beazley appointed |
|
12/03/2013 |
Ms C.G. Regan has resigned as company secretary |
|
12/03/2013 |
New Board Member Mr S.M. Wort appointed |
|
12/03/2013 |
New Company Secretary Mrs S. Cookman appointed |
|
13/12/2012 |
New Accounts Filed |
|
13/12/2012 |
New Accounts Filed |
|
14/09/2012 |
Annual Returns |
|
26/07/2012 |
Mr L.O. Sanden has left the board |
|
Date |
Previous Name |
|
22/07/2003 |
ELEKTA ONCOLOGY SYSTEMS LTD |
|
30/01/1997 |
REFAL 496 LIMITED |
No writs found
|
Group |
4 companies |
|
Linkages |
30 companies |
|
Countries |
In 24 countries |
|
Holding Company |
ELEKTA HOLDINGS LIMITED |
|
Ownership Status |
Wholly Owned |
|
Ultimate Holding Company |
ELEKTA AB (PUBL) |
|
Company Name |
Registered Number |
Latest Key
Financials |
Consol. Accounts |
Turnover |
|
ELEKTA AB (PUBL) |
5561704015 |
30.04.2014 |
Y |
|
|
CMS WORLDWIDE INC |
N/A |
- |
- |
|
|
ELEKTA HOLDINGS LIMITED |
02699176 |
30.04.2014 |
N |
|
|
ELEKTA LIMITED |
03244454 |
30.04.2014 |
N |
£490,679,000 |
|
Name |
Number |
Latest Key
Financials |
Turnover |
|
ELEKTA GMBH |
HRB 125109 |
30.04.2013 |
€59,655,567 |
|
ELEKTA S.P.A. |
MI1972717 |
30.04.2013 |
€43,282,620 |
|
ELEKTA INSTRUMENT AB |
5564920949 |
30.04.2014 |
1,298,655 KSEK |
|
ELEKTA |
414404913 |
30.04.2014 |
€36,467,094 |
|
MEDICAL INTELLIGENCE MEDIZINTECHNIK GMBH |
HRB 14835 |
30.04.2014 |
€31,165,727 |
|
ELEKTA B.V. |
17097384 |
30.04.2013 |
|
|
3D LINE RESEARCH AND DEVELOPMENT S.R.L. |
MI1843687 |
30.04.2013 |
€2,270,759 |
|
LEKSELL INSTITUTE AB |
5569426314 |
30.04.2014 |
|
|
NUCLETRON B.V. |
30085856 |
- |
|
|
ELEKTA MEDICAL |
41472 |
30.04.2014 |
€25,686,909 |
|
ELEKTA NV |
460510369 |
30.04.2014 |
€8,929,820 |
|
DELFT INSTRUMENTS GMBH |
- |
||
|
ELEKTA (PTY) LTD |
- |
||
|
ELEKTA ASIA LTD |
- |
||
|
ELEKTA BMEI (BEIJING) MEDICAL EQUIPMENT CO
LTD |
- |
||
|
ELEKTA CANADA INC |
- |
||
|
ELEKTA GMBH |
- |
||
|
ELEKTA HELLAS EPE |
- |
||
|
ELEKTA HOLDING LIMITED |
- |
||
|
ELEKTA HOLDING US INC |
- |
|
Mortgage Type: |
MORTGAGE |
||
|
Date Charge
Created: |
10/05/00 |
||
|
Date Charge
Registered: |
12/05/00 |
||
|
Date Charge
Satisfied: |
19/03/01 |
||
|
Status: |
SATISFIED |
||
|
Person(s)
Entitled: |
FRED HUTCHINSON CANCER RESEARCH CENTER |
||
|
Amount Secured: |
ALL MONIES DUE OR TO BECOME DUE FROM THE COMPANY TO THE
CHARGEE IN RELATION TOTHE PURCHASE AGREEMENT DATED 27 JULY 1999 (AS DEFINED) AND
UNDER THIS MORTGAGE |
||
|
Details: |
THE EQUIPMENT AND ALL INSURANCES THEREON SEE THE MORTGAGE
CHARGE DOCUMENT FOR FULL DETAILS |
||
|
Name |
Current
Directorships |
Previous
Directorships |
|
Laurent Leksell |
0 |
4 |
|
David Charles Carter |
9 |
44 |
|
Jonas Serlachius |
0 |
2 |
|
Jonas Serlachius |
0 |
2 |
|
Frank Harris Low |
0 |
1 |
|
Manfred Sturm |
0 |
4 |
|
Manfred Sturm |
0 |
4 |
|
Volker Steiber |
0 |
2 |
|
Mans Ekelof |
0 |
2 |
|
Fritz Harald Nils Bauer |
2 |
3 |
|
Fritz Harald Nils Bauer |
2 |
3 |
|
Per Gronwall |
0 |
2 |
|
Catherine Geraldine Regan |
3 |
24 |
|
Adrian Boxwell Leared |
0 |
4 |
|
Adrian Boxwell Leared |
0 |
4 |
|
Asa Maria Widholm Thunman |
0 |
2 |
|
Jeffrey Robert Boyman |
1 |
4 |
|
Jeffrey Robert Boyman |
1 |
4 |
|
Nils Chriser Sverker Glans |
0 |
1 |
|
Samantha Jane Cookman |
2 |
1 |
|
Joseph K Jachinowski |
0 |
1 |
|
James Peter Hoey |
0 |
1 |
|
Lars Olof Sanden |
0 |
1 |
|
George Russell Sandars |
34 |
165 |
|
Average Invoice Value |
Ł1014.77 |
|
Invoices available |
105 |
|
Paid |
104 |
|
Outstanding |
1 |
|
Trade Payment Data is information that we collect from
selected third party partners who send us information about their whole sales
ledger. |
|
Within Terms |
0-30 Days |
31-60 Days |
61-90 Days |
91+ Days |
|
|
Paid |
87 |
14 |
2 |
1 |
0 |
|
Outstanding |
0 |
1 |
0 |
0 |
0 |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.63.52 |
|
|
1 |
Rs.95.96 |
|
Euro |
1 |
Rs.70.54 |
INFORMATION DETAILS
|
Analysis Done by
: |
RAS |
|
|
|
|
Report Prepared
by : |
VNT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major sections
of this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.